Pilot Translational Studies

Pilot Translational Studies—Pre-clinical studies designed to validate a therapeutic target that uses in vivo or in vitro models. These projects require a clinical researcher to serve as co-PI to assure disease relevance. Up to $25,000 per award.

Translational research is defined to include four emphases:

  1. Phase 1 translational research includes the process of applying basic research discoveries to develop trials and other studies in humans (i.e., case series, phase I and II clinical trials).
  2. Phase 2 translational research is directed at better patient outcomes and the development of evidence
  3. Phase 3 translational research implements evidencebased guidelines into health practice through community practice (delivery, dissemination, and diffusion research).
  4. Phase 4 translational research evaluates the health outcomes of applications of translational research in the community.

Proposals are not currently being accepted. Check back in Sept, 2011 for a new RFA.